Literature DB >> 15998221

De novo reconstruction of functional bone by tissue engineering in the metatarsal sheep model.

W Bensaïd1, K Oudina, V Viateau, E Potier, V Bousson, C Blanchat, L Sedel, G Guillemin, H Petite.   

Abstract

Large bone defects are still a challenge to orthopedic surgeons. In this study, a massive bone defect with a clinically relevant volume was efficiently reconstructed by transplanting an engineered bone in which mesenchymal stem cells (MSCs) expanded in autologous serum (AS) were combined with a porous scaffold. In the first step, we established that the way in which the MSCs are distributed over the scaffold affects the ultimate bone-forming ability of the transplant: constructs consisting of a natural coral scaffold and a pseudo-periosteal layer of MSCs surrounding the implant (coral-MSC3D) formed significantly more bone than constructs in which the MSCs were distributed throughout the implant (p = 0.01). However, bone healing occurred in only one sheep, owing to the high resorption rate of natural coral scaffold. To overcome this problem, constructs in which MSCs were combined with a porous coralline-based hydroxyapatite (CHA) scaffold having the same architecture as natural coral but a lower resorption rate were prepared. After their implantation, these constructs were found to have the same osteogenic potential as autologous bone grafts in terms of the amount of newly formed bone present at 4 months (p = 0.89) and to have been completely replaced by newly formed, structurally competent bone within 14 months. Nevertheless, although the rate of bone healing was strikingly improved when CHA-MSC3D constructs were used (five of seven animals healed) as compared with the coral-MSC3D construct (one of seven healed), it was still less satisfactory than that obtained with autografts (five of five healed).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15998221     DOI: 10.1089/ten.2005.11.814

Source DB:  PubMed          Journal:  Tissue Eng        ISSN: 1076-3279


  19 in total

Review 1.  Strategies for improving the efficacy of bioengineered bone constructs: a perspective.

Authors:  H Petite; K Vandamme; L Monfoulet; D Logeart-Avramoglou
Journal:  Osteoporos Int       Date:  2011-06       Impact factor: 4.507

2.  Comprehensive histological evaluation of bone implants.

Authors:  Claudia Rentsch; Wolfgang Schneiders; Suzanne Manthey; Barbe Rentsch; Stephan Rammelt
Journal:  Biomatter       Date:  2014-02-06

Review 3.  Induced membrane for treatment of critical sized bone defect: a review of experimental and clinical experiences.

Authors:  Jean-Charles Aurégan; Thierry Bégué
Journal:  Int Orthop       Date:  2014-07-02       Impact factor: 3.075

Review 4.  Engineering bone: challenges and obstacles.

Authors:  D Logeart-Avramoglou; F Anagnostou; R Bizios; H Petite
Journal:  J Cell Mol Med       Date:  2005 Jan-Mar       Impact factor: 5.310

Review 5.  Stem cell homing in musculoskeletal injury.

Authors:  Eliza L S Fong; Casey K Chan; Stuart B Goodman
Journal:  Biomaterials       Date:  2010-10-08       Impact factor: 12.479

6.  Clinical application of human mesenchymal stromal cells for bone tissue engineering.

Authors:  Anindita Chatterjea; Gert Meijer; Clemens van Blitterswijk; Jan de Boer
Journal:  Stem Cells Int       Date:  2010-11-11       Impact factor: 5.443

7.  Engraftment of Prevascularized, Tissue Engineered Constructs in a Novel Rabbit Segmental Bone Defect Model.

Authors:  Alexandre Kaempfen; Atanas Todorov; Sinan Güven; René D Largo; Claude Jaquiéry; Arnaud Scherberich; Ivan Martin; Dirk J Schaefer
Journal:  Int J Mol Sci       Date:  2015-06-04       Impact factor: 5.923

8.  Mesenchymal stem cells and platelet gel improve bone deposition within CAD-CAM custom-made ceramic HA scaffolds for condyle substitution.

Authors:  L Ciocca; D Donati; S Ragazzini; B Dozza; F Rossi; M Fantini; A Spadari; N Romagnoli; E Landi; A Tampieri; A Piattelli; G Iezzi; R Scotti
Journal:  Biomed Res Int       Date:  2013-09-01       Impact factor: 3.411

9.  Survival and function of mesenchymal stem cells (MSCs) depend on glucose to overcome exposure to long-term, severe and continuous hypoxia.

Authors:  M Deschepper; K Oudina; B David; V Myrtil; C Collet; M Bensidhoum; D Logeart-Avramoglou; H Petite
Journal:  J Cell Mol Med       Date:  2011-07       Impact factor: 5.310

10.  Saving Implants BMP-2 Application in Revision Total Hip Surgery.

Authors:  M Jäger; R Emami; F Thorey; R Krauspe
Journal:  Int J Biomed Sci       Date:  2006-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.